Jefferies Group
LRMR icon

Jefferies Group’s Larimar Therapeutics LRMR Stock Holding History

Jefferies Group’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,220
Closed -$32K – 2883
2019
Q2 		$32K Buy
+2,220
New +$59.1K ﹤0.01% 2400
2018
Q2 		– Sell
-1,108
Closed -$99K – 2523
2018
Q1 		$99K Buy
+1,108
New +$93.9K ﹤0.01% 2062
2016
Q2 		– Sell
-1,963
Closed -$157K – 2305
2016
Q1 		$157K Sell
1,963
-1,750
-47% -$138K ﹤0.01% 1895
2015
Q4 		$280K Buy
3,713
+1,736
+88% +$279K ﹤0.01% 1808
2015
Q3 		$758K Buy
1,977
+1,870
+1,748% +$843K ﹤0.01% 1329
2015
Q2 		$45K Buy
+107
New +$44.8K ﹤0.01% 2467

Other funds holding LRMR

AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Jefferies Group's LRMR Position: Q3 2019 in Review

Jefferies Group sold out of Larimar Therapeutics (LRMR) in Q3 2019, closing a stake of 2,220 shares — an estimated $32K sold.

Jefferies Group first reported a position in LRMR in Q2 2015 and held it in 6 quarters. The position peaked at $758K in Q3 2015. 51 funds tracked by Wall St. Rank hold LRMR as of Q3 2019.

  • Jefferies Group reported no remaining Larimar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 2,220 Larimar Therapeutics shares in Q3 2019, an estimated $32K.
  • Jefferies Group first reported a position in Larimar Therapeutics in Q2 2015 and held it in 6 quarters.
  • Jefferies Group's Larimar Therapeutics position peaked at $758K in Q3 2015.
  • 51 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.